Clinical Trials Logo

SCI - Spinal Cord Injury clinical trials

View clinical trials related to SCI - Spinal Cord Injury.

Filter by:

NCT ID: NCT04506099 Withdrawn - Neuropathic Pain Clinical Trials

Transcutaneous Intercostal Nerve Stimulation in Spinal Cord Injury

TINS
Start date: July 17, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the safety, feasibility, and effectiveness of electric stimulation of the nerves along the intercostal nerves on pain and spasticity in spinal cord injury patients.

NCT ID: NCT03702842 Active, not recruiting - Clinical trials for Incomplete Spinal Cord Injury

Stimulation to Enhance Walking Post-SCI

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This study will investigate the effects of transcutaneous direct current stimulation (tsDCS) on walking function in individuals with incomplete spinal cord injury. Following rehabilitation, individuals with ISCI often demonstrate improved walking function, but continue to have serious impairments that limit mobility, community participation and quality of life. Adjuvants to rehabilitation that increase spinal excitation during training may enhance its effectiveness. tsDCS is a non-invasive neuromodulation approach that uses a mild electrical current, applied over the skin of the low back, to alter the membrane potential of spinal neurons. tsDCS will be applied during locomotor training, a well-established rehabilitation strategy that promotes walking recovery. Locomotor training emphasizes repetitive and task-specific practice of coordinated walking, often with therapist assistance or cueing to promote high quality movement patterns. The study team will explore if tsDCS combined with locomotor training increases spinal excitation and thereby improves the effectiveness of walking rehabilitation.

NCT ID: NCT03698149 Recruiting - Stroke Clinical Trials

ECoG BMI for Motor and Speech Control

BRAVO
Start date: November 9, 2018
Phase: N/A
Study type: Interventional

Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.

NCT ID: NCT03352505 Completed - Clinical trials for Cardiovascular Risk Factor

Cardiovascular Risk Markers in Spinal Cord Injured Subjects of the Wheelchair Dancer Study

Start date: October 1, 2017
Phase:
Study type: Observational

The present study will analyze if exercise is able to elicit the well-known anti-atherogenic effects in patients with SCI. This will be evaluated by measuring vascular parameters such as endothelial and inflammatory blood markers, echocardiography of the heart and peripheral vessels, as well as blood pressure and arterial stiffness, in subjects performing either wheelchair dancing, wheelchair marathon or no sports. Further, it will be investigated, whether there is an association between neuroplasticity and cardiovascular health, as measured by electroencephalography (EEG), transcranial magnetic stimulation (TMS) and blood levels of the brain-derived neurotrophic factor (BDNF). We hypothesize that the cardiovascular, physical and psychological benefits of wheelchair dancing and/or wheelchair marathon parallel improved neuroplasticity in SCI-patients

NCT ID: NCT03225625 Enrolling by invitation - Clinical trials for Spinal Cord Injuries

Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study

SciExVR
Start date: July 1, 2017
Phase: N/A
Study type: Interventional

The SciExVR study will evaluate the potential benefit of autologous bone marrow derived stem cells (BMSC) in the treatment of spinal cord injury with evidence of impaired motor or sensory function. The treatment consists of bilateral paraspinal injections of the BMSC at the level of the injury as well as superior and inferior to that spinal segment followed by an intravenous injection and intranasal placement. Patients undergoing BMSC treatment may also be assigned to use of exoskeletal movement (or equivalent) or virtual reality visualization (or equivalent) to augment upper motor neuron firing and/or receptivity of the sensory neurons. http://mdstemcells.com/sciexvr/

NCT ID: NCT03175055 Completed - Clinical trials for SCI - Spinal Cord Injury

Phoenix Exoskeleton for SCI Users

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

This study will evaluate the Phoenix device for safety and effectiveness at allowing persons with SCI who are non-ambulatory or poorly ambulatory to stand up and walk under a variety of conditions.

NCT ID: NCT03052244 Not yet recruiting - Clinical trials for SCI - Spinal Cord Injury

tDCS and VI to Treat Neuropathic Pain and Function in SCI

Start date: March 15, 2017
Phase: N/A
Study type: Interventional

Transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) will be applied for patient who suffer from neuropathic pain following spinal cord injury The tDCS treatment will be coupled with a video of a man walking (creating a visual illusion) in order to enhance functional ability and reduce pain